Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > L2

<< Previous

Bullboard Posts

Next >>

Post by Bungeon Jan 20, 2021 9:05am

178 Views

Post# 32332198

L2

Level 2 Quote

Level two quotes - Bid
Number of Shares		Bid Price
59,500 shares	59,500	0.225
25,500 shares	25,500	0.220
10,000 shares	10,000	0.215
70,000 shares	70,000	0.210
10,000 shares	10,000	0.205
41,000 shares	41,000	0.200
10,000 shares	10,000	0.195
30,000 shares	30,000	0.190
50,000 shares	50,000	0.185
10,000 shares	10,000	0.180

Level two quotes - Ask
Ask Price	Number of Shares
0.225	72,000	72,000 shares
0.230	60,000	60,000 shares
0.235	120,000	120,000 shares
0.240	43,500	43,500 shares
0.245	37,000	37,000 shares
0.250	157,000	157,000 shares
0.255	17,500	17,500 shares
0.260	44,500	44,500 shares
0.265	80,000	80,000 shares
0.270	13,500